301 related articles for article (PubMed ID: 8729206)
1. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.
Linden PK; Pasculle AW; Manez R; Kramer DJ; Fung JJ; Pinna AD; Kusne S
Clin Infect Dis; 1996 Apr; 22(4):663-70. PubMed ID: 8729206
[TBL] [Abstract][Full Text] [Related]
2. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
[TBL] [Abstract][Full Text] [Related]
3. Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization.
Webb M; Riley LW; Roberts RB
Clin Infect Dis; 2001 Aug; 33(4):445-52. PubMed ID: 11462178
[TBL] [Abstract][Full Text] [Related]
4. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort.
Linden PK; Pasculle AW; McDevitt D; Kramer DJ
J Antimicrob Chemother; 1997 May; 39 Suppl A():145-51. PubMed ID: 9511079
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients.
Tornieporth NG; Roberts RB; John J; Hafner A; Riley LW
Clin Infect Dis; 1996 Oct; 23(4):767-72. PubMed ID: 8909842
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-resistant Enterococcus faecium in a long-term care facility.
Brennen C; Wagener MM; Muder RR
J Am Geriatr Soc; 1998 Feb; 46(2):157-60. PubMed ID: 9475442
[TBL] [Abstract][Full Text] [Related]
7. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.
Garbutt JM; Ventrapragada M; Littenberg B; Mundy LM
Clin Infect Dis; 2000 Mar; 30(3):466-72. PubMed ID: 10722429
[TBL] [Abstract][Full Text] [Related]
8. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality.
Papanicolaou GA; Meyers BR; Meyers J; Mendelson MH; Lou W; Emre S; Sheiner P; Miller C
Clin Infect Dis; 1996 Oct; 23(4):760-6. PubMed ID: 8909841
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
10. Differential antimicrobial susceptibility between human and chicken isolates of vancomycin-resistant and sensitive Enterococcus faecium.
Chen HY; Hill RL; Kirk M; Casewell MW; Beighton D
Int J Antimicrob Agents; 2002 Jan; 19(1):39-46. PubMed ID: 11814766
[TBL] [Abstract][Full Text] [Related]
11. Enterococcus faecium bacteremia: does vancomycin resistance make a difference?
Stosor V; Peterson LR; Postelnick M; Noskin GA
Arch Intern Med; 1998 Mar; 158(5):522-7. PubMed ID: 9508230
[TBL] [Abstract][Full Text] [Related]
12. Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia.
Ricaurte JC; Boucher HW; Turett GS; Moellering RC; Labombardi VJ; Kislak JW
Clin Microbiol Infect; 2001 Jan; 7(1):17-21. PubMed ID: 11284938
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin-resistant Enterococcus faecium Bacteremia in a tertiary care hospital: epidemiology, antimicrobial susceptibility, and outcome.
Rosa RG; Schwarzbold AV; Dos Santos RP; Turra EE; Machado DP; Goldani LZ
Biomed Res Int; 2014; 2014():958469. PubMed ID: 24729981
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
Lucas GM; Lechtzin N; Puryear DW; Yau LL; Flexner CW; Moore RD
Clin Infect Dis; 1998 May; 26(5):1127-33. PubMed ID: 9597241
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.
Hayakawa K; Marchaim D; Martin ET; Tiwari N; Yousuf A; Sunkara B; Pulluru H; Kotra H; Hasan A; Bheemreddy S; Sheth P; Lee DW; Kamatam S; Bathina P; Nanjireddy P; Chalana IK; Patel S; Kumar S; Vahia A; Ku K; Yee V; Swan J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS
Antimicrob Agents Chemother; 2012 May; 56(5):2452-8. PubMed ID: 22354290
[TBL] [Abstract][Full Text] [Related]
16. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
Britt NS; Potter EM; Patel N; Steed ME
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
[TBL] [Abstract][Full Text] [Related]
17. Natural history of colonization with vancomycin-resistant Enterococcus faecium.
Montecalvo MA; de Lencastre H; Carraher M; Gedris C; Chung M; VanHorn K; Wormser GP
Infect Control Hosp Epidemiol; 1995 Dec; 16(12):680-5. PubMed ID: 8683085
[TBL] [Abstract][Full Text] [Related]
18. Emergence of unusual vanA/vanB
Santona A; Taviani E; Hoang HM; Fiamma M; Deligios M; Ngo TVQ; Van Le A; Cappuccinelli P; Rubino S; Paglietti B
Int J Antimicrob Agents; 2018 Nov; 52(5):586-592. PubMed ID: 30012442
[TBL] [Abstract][Full Text] [Related]
19. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium.
Mondy KE; Shannon W; Mundy LM
Clin Infect Dis; 2001 Aug; 33(4):473-6. PubMed ID: 11462182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
